Managing COVID-19. Medical positives from 2020.
COVID has made 2020 a touch year for many, but there have been positives. One positive outcome of COVID-19 is that it has focused mankind on many anti-viral medical treatments, not only for COVID-19. And it has focused minds on processes to manage future global pandemics, including highlighting weakness (that need to be fixed) in relevant global institutions and in funding for treatments for both viruses and bacteria that may threaten mankind. Leaving it up to the free market and pharmaceutical companies is not an adequate answer because many required medical "solutions" are not commercially attractive to pharmaceutical companies including:
development of new antibiotics - to deal with the growing problem of multi-resistant microbes.
https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance Antimicrobial resistance, World Health Organisation
https://amr-review.org/ "Review on Antimicrobial Resistance" Jim O'Neill
Preparing for future pandemics
18/Mar/2015 Bill Gates - "We’re not ready for the next epidemic" https://www.gatesnotes.com/health/we-are-not-ready-for-the-next-epidemic
http://puzzlefinancialadvice.com.au/2020/AFR/200822_AFR_Oxford_Uni_COVID19_vaccine_started_2017_with_Bill_Gates_$100m_funding_generic_vaccine_platform.pdf Development of Oxford University's COVID-19 vaccine commenced in 2017 with funding from Bill Gates.
But to 2020 medical developments - triggered by the COVID crisis, this is a great article, discussing progress in development of antivirals, biologicals, and adjuvants etc - much more than just vaccines.